Patent assignee · FR · COMPANY

Centre Hospitalier Regional Universitaire de Montpellier

17Patents

17Active

17Granted

45Portfolio score

Filing activity: Jan 17, 2013 → Jun 23, 2022

Most-cited patents

Patent	Title	Area	Cited by	Status
US10640542B2	Fusokines involving cytokines with strongly reduced receptor binding affinities	Chemistry; Metallurgy	17	Active
US9732135B2	Targeting of human interferon antagonists	Chemistry; Metallurgy	16	Active
US9878014B2	Targeted human-interferon fusion proteins	Chemistry; Metallurgy	14	Active
US9492562B2	Targeted human-interferon fusion proteins	Chemistry; Metallurgy	14	Active
US10034919B2	Targeted human-interferon fusion proteins	Chemistry; Metallurgy	13	Active
US10072059B2	Targeting of human interferon antagonists	Chemistry; Metallurgy	13	Active
US9932409B2	Targeted modified IL-1 family members	Chemistry; Metallurgy	13	Active
US9914759B2	Targeted modified TNF family members	Chemistry; Metallurgy	13	Active
US10035835B2	Targeted modified TNF family members	Chemistry; Metallurgy	12	Active
US10407480B2	Targeted modified TNF family members	Chemistry; Metallurgy	12	Active
US10787493B2	Targeted modified TNF family members	Chemistry; Metallurgy	4	Active
US10947288B2	Targeting of human interferon antagonists	Chemistry; Metallurgy	3	Active
US10946070B2	Targeted and mutated human-interferon fusion proteins	Chemistry; Metallurgy	3	Active
US11358997B2	Fusokines involving cytokines with strongly reduced receptor binding affinities	Chemistry; Metallurgy	1	Active
US12227550B2	Targeted modified TNF family members	Chemistry; Metallurgy	0	Active
US11396532B2	Targeted modified TNF family members	Chemistry; Metallurgy	0	Active
US12410222B2	Fusokines involving cytokines with strongly reduced receptor binding affinities	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.